Kolangitis Akut pada Penderita Tumor Klatskin

Muhamad Ayus Astoni(1*), Syadra Bardiman(2), Mitayani Purwoko(3)


(1) FK UMPalembang, Palembang, South Sumatera, Indonesia
(2) RSUD BARI, Palembang RS Moechamad Hoesin, Palembang, South Sumatera, Indonesia
(3) FK UMPalembang, Palembang, South Sumatera, Indonesia
(*) Corresponding Author

Abstract


Acute cholangitis in patients with Klatskin tumor

 

Tumor Klatskin merupakan suatu kolangiokarsinoma tipe ekstrahepatik yang bersifat ganas dan timbul dari epitel duktus koledokus dan kedua percabangannya. Seorang wanita usia 47 tahun mengalami keluhan badan panas sejak 1 hari sebelum masuk rumah sakit. Satu hari sebelum masuk rumah sakit, pasien mengalami demam tinggi terus- menerus, tidak disertai dengan menggigil. Keluhan disertai nyeri hebat di perut kanan atas sampai ke ulu hati, nafsu makan menurun, mual setiap hendak makan, BAK berwarna seperti teh, BAB biasa, dan mata terlihat kuning. Satu minggu sebelum masuk rumah sakit, keluhan nyeri perut makin sering timbul disertai demam, mual, kadang-kadang muntah bila makan, dan nafsu makan makin turun. Hasil MRI menunjukkan kesan lesi hipointens dengan tepi yang irreguler di distal CBD sepanjang ±2 cm dengan dilatasi sedang CBD di bagian proksimalnya dan dilatasi ringan IHBD serta tak tampak dilatasi pada duktus pankreatikus, mengesankan massa di distal CBD yang menyebabkan obstruksi, curiga Klatskin Tumor Type 1 (berdasarkan Bismuth Classification). Pasien menolak dilakukan tindakan pembedahan maupun kemoterapi. Pasien mengaku merasa dalam kondisi baik, keluhan nyeri perut sangat jarang, nafsu makan sudah meningkat.

 

Klatskin tumor is an malignant extrahepatic type of cholangiocarcinoma and arises from the choledocus ducte pithelium and its two branches. A 47-year-oldwoman has afever since one day before being hospitalized. One day before being admitted to the hospital, the patient experienced a persistent high fever, not accompanied by shivering. Complaints accompanied by severe pain in the right upper abdomen to the epigastrium, decreasedappetite, nausea, urine coloredliketea, normal bowelmovements, and eyes look yellow. One week before being hospitalized, complaintsof abdominal pain often came with fever, nausea, sometimes vomiting when eating, and appetite decreased. The MRI results showed hypointense lesions with irregular edges in the distal CBD of ±2 cm with moderate CBD dilatation in the proximal part and mild IHBD dilatation and no visible dilatation of the pancreatic ducts, impressive distal CBD mass causing obstruction, suspicious of Klatskin Tumor Type 1 (basedonBismuthClassification). Patient refused surgeryor chemotherapy. Patient claimed to feel in good condition, complaints of abdominal pain was veryrare, appetite has increased. 




Keywords


acutecholangitis; Klatskin tumor; cholangitis

Full Text:

PDF

References


deGroen PC, Gores GJ, LaRusso NF, etal.Biliarytractcancers. N EnglJMed 1999;341: 1368–78.

Hirohashi K, Venishi T, Kubo S, etal. Macroscopic types of intrahepatic cholangio carcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 2002;49: 326–9.

Olnes MJ, Erlich R. A review and update on cholangio carcinoma. Oncology 2004;66: 167–79.

Alejandro Serrablo, Luis Tejedor. Outcome of surgical resection in Klatskin tumors. World J GastrointestOncol2013 July 15; 5(7): 147-158.

Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004; 99: 523-526.

Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology1999; 30: 325-332.

Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broomé U, Chapman R, Fausa O, Egeland T, Rocca G, Schrumpf E. Cholangio carcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol2002; 37: 1205-1211.

Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Lööf L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzén H, Almer S, Granath F, Broomé U. Hepaticandextrahepaticmalignancies in primarysclerosingcholangitis. J Hepatol2002; 36: 321-327.

Mert A, Ozaras R, Tabak F, Ozturk R, Bilir M. Tumor Klatskin. Eur J Intern Med 2003;14:511.

Khan SA, etal.Guidelinesforthe diagnosis and treatment of cholangio carcinoma: consensus document. Gut 2002;51(Suppl 6):VI1–9.

Nehls O, Gregor M, Klump B. Serum and bile markers for cholangio carcinoma. Semin Liver Dis 2004; 24: 139-154.

Alvaro D, Macarri G, Mancino MG, Marzioni M, Bragazzi M, Onori P, Corradini SG, Invernizzi P, Franchitto A, Attili AF, Gaudio E, Benedetti A. Serum andbiliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis. Ann Intern Med2007; 147: 451-459.

Nagorney DM, Kendrick ML. Hepaticresection in the treatment of hilar cholangio carcinoma. Adv Surg 2006;40:159–71.

Patel T. Cholangio carcinoma. Nat Clin Pract Gastroenterol Hepatol 2006;3:33–42.

Jarnagin WR, Shoup M. Surgical management of cholangiocarcinoma. SeminLiver Dis 2004;24:189–99.

Zhang W.Z., Chen Y.S., Wang J.W, etal. Early diagnosis and treatment of severe acute cholangitis. World J Gastroenterol (2002); 8(1):150-152.

Malet P.F. Acute Bacterial Cholangitis, In Kaplowitz N, Ed. Liver and Biliary Diseases. 2 nd Ed, Williams andWilkins, Baltimore. (1996) : 685-687.

Sartelli M., Cristian Tranà C. A focuson acute cholecystitis and acute cholangitis. Journal of Acute Disease (2012): 77-81.

Qin Y.S., Li Q.Y., Yang F.C. Riskfactorsandincidenceofacutepyogeniccholangitis. HepatobiliaryPancreat Dis Int,(2012): 11(6): 650-54. http://jurnal.unimus.ac.id

Muhamad Ayus Astoniet al19 Vol. 1 No.5 Agustus 2018

Beuers U. BiiaryInfection, in Dancygier H, Ed. Clinical Hepatology. Springer-Verlag Berlin Heidelberg (2010): 1493-1502.

Basoli A, Schietroma M, DeSantis A, etal. Acute cholangitis: diagnostic and therapeutic problems. Italian J SurgSci (1996) : 16:261–267.

Kiriyama S, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Pitt HA, etal. New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. J HepatobiliaryPancreatSci. 2012;19:548–56.

Tsuyuguchi T, Sugiyama H, Sakai Y, Nishikawa T, Yokosuka O, Mayumi T, etal. Prognostic factors of acute cholangitis in cases manage dusingthe Tokyo Guidelines. J Hepatobiliary PancreatSurg. 2012;19:557–65


Article Metrics

Abstract view : 3253 times
PDF - 468 times

DOI: https://doi.org/10.26714/magnamed.1.5.2018.11-19

Refbacks

  • There are currently no refbacks.




Indexed by

 

      

 

Creative Commons License

MAGNA MEDIKA by APKKM is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.